Koa Shoji Holdings Co.,Ltd. (TYO:9273)

Market Cap	34.62B +4.2%
Revenue (ttm)	24.68B +6.1%
Net Income	3.75B +3.1%
EPS	88.99 +3.1%
Shares Out	42.12M
PE Ratio	9.24
Forward PE	n/a
Dividend	19.00 (2.31%)
Ex-Dividend Date	Jun 29, 2026

Volume	51,900
Open	833.00
Previous Close	830.00
Day's Range	820.00 - 839.00
52-Week Range	737.00 - 919.00
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About Koa Shoji Holdings

Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells active pharmaceutical ingredients (APIs) in Japan. It operates through Active Pharmaceutical Ingredient Sales Business and Pharmaceutical Manufacturing and Sales Business segments. The company is involved in the manufacture and sale of over-the-counter drugs and pharmacologically active injection. It also engages in contract manufacturing of pharmaceuticals; and purchase and sale of pharmaceuticals. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 318
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9273

Financial Performance

In fiscal year 2026, Koa Shoji Holdings's revenue was 24.68 billion, an increase of 6.06% compared to the previous year's 23.27 billion. Earnings were 3.75 billion, an increase of 3.05%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 23, 2026

Data Sources Report a data error